SUSMED,Inc. Cash Flow Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-297	-356	-49	-233	-
Depreciation & Amortization	7	5	5	2	-
Loss (Gain) From Sale of Assets	4	2	5	15	-
Other Operating Activities	-	1	-	51	-
Change in Accounts Receivable	-5	-	-1	-3	-
Change in Accounts Payable	4	-14	11	-15	-
Change in Other Net Operating Assets	-145	132	129	18	-
Operating Cash Flow	-432	-230	100	-165	-
Capital Expenditures	-4	-3	-6	-12	-
Sale (Purchase) of Intangibles	-15	-6	-12	-	-
Other Investing Activities	-	1	-	-8	-
Investing Cash Flow	-19	-8	-18	-20	-
Issuance of Common Stock	3	37	61	3,481	-
Other Financing Activities	-	-	1	-18	-
Financing Cash Flow	3	37	62	3,463	-
Miscellaneous Cash Flow Adjustments	-	-	-	-1	-
Net Cash Flow	-448	-201	144	3,277	-
Free Cash Flow	-436	-233	94	-177	-
Free Cash Flow Margin	-94.37%	-68.13%	17.74%	-56.01%	-
Free Cash Flow Per Share	-25.96	-13.96	5.73	-12.05	-
Cash Income Tax Paid	1	1	1	-	-
Levered Free Cash Flow	-407.5	-150.13	88	-145.75	-
Unlevered Free Cash Flow	-407.5	-150.13	88	-145.75	-
Change in Working Capital	-146	118	139	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.